Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of a Proteomic Biomarker to Predict Progression of Chronic Kidney Disease

NCT06962891 is registered in ClinicalTrials.gov with Angel Argiles as lead sponsor.

NCT NCT06962891
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06962891 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of a Proteomic Biomarker to Predict Progression of Chronic Kidney Disease
Lead sponsor
Angel Argiles
Phase
Observational
Overall status
Active, not recruiting
Start date
May 2, 2023
Completion date
May 1, 2026
Enrollment
213 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease(ckd), progression, disease